U.S. panel nears vote on Glaxo diabetes drug

Published July 15, 2010

U.S. panel nears vote on Glaxo diabetes drug
The fate of a GlaxoSmithKline Plc diabetes drug may become clearer on Wednesday when U.S. advisers vote on whether the widely used pill carries too much heart risk to stay on the market.
Read more on Reuters via Yahoo! News

Helix Bioscience Appointed DNA Drug Sensitivity Testing Distributor For Genelex Corporation
Genelex and Helix have announced a personalized prescribing strategic alliance to increase the availability of important new DNA Drug Sensitivity Tests such as Plavitest™ and Tamoxitest™.
Read more on PharmaceuticalOnline

Plavix may be treatment for dogs at risk of thromboembolic disease
Companion animals that have a long-term need for anticoagulant drug therapies may soon find help in a top-selling antiplatelet drug marketed to humans: clopidogrel, commonly known by the trade-name Plavix.
Read more on PhysOrg